CorMedix Inc.
(NYSE Amex Equities : CRMD)

( )
CRMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.29%95.750.6%$578.30m
ABTAbbott Laboratories
1.02%72.570.8%$496.37m
ISRGIntuitive Surgical, Inc.
1.49%515.632.4%$402.42m
TMOThermo Fisher Scientific Inc.
1.61%241.321.0%$389.37m
BAXBaxter International Inc.
1.21%66.991.7%$319.84m
ALGNAlign Technology, Inc.
-0.45%219.296.3%$294.66m
BSXBoston Scientific Corporation
1.48%37.101.1%$294.20m
DXCMDexCom, Inc.
1.21%124.528.5%$282.64m
BDXBecton, Dickinson and Company
-0.43%235.641.1%$261.37m
EWEdwards Lifesciences Corporation
-0.01%163.181.2%$234.05m
SYKStryker Corporation
0.58%172.651.3%$233.25m
ABMDABIOMED, Inc.
0.78%330.693.3%$228.42m
ZBHZimmer Biomet Holdings, Inc.
0.84%112.951.7%$127.75m
XRAYDENTSPLY International Inc.
3.03%38.123.1%$107.77m
WATWaters Corporation
0.31%190.373.5%$106.34m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.